Shares of Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) plummeted $4.37 to $2.65 after the company reported disappointing results for its drug candidate that treats dizziness.
Disappointing Results For Chelsea's Dizziness Treatment
September 24, 2009 at 14:28 PM EDT
